Marriage Counselors in Rosedale, MD Accepting Medicare

1 Marriage Counselors found. Showing 1 - 1

Gladys Ogario Chang Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 9627 Philadelphia Rd Ste 160, Rosedale, MD 21237 Phone: 410-780-5203

News Archive

Stunner on birth control: Trump's moral exemption is geared to just 2 groups

Few people were surprised last week when the Trump administration issued a rule to make it easier for some religious employers to opt out of offering no-cost prescription birth control to their female employees under the Affordable Care Act.

Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy

Immunomic Therapeutics, Inc., a leader in developing novel allergy immunotherapies, announced today that it has dosed the first patient in a Phase I clinical trial of its lead candidate, JRC-LAMP-vax vaccine, at its clinical site in Honolulu, Hawaii. Initial subjects include Japanese ex-patriates previously exposed to Japanese red cedar, or "Sugi," as it is known in Japan.

New trial shows how parents can avoid bringing dangerous bacteria into the NICU

For sick or prematurely born babies spending their first days of life in a hospital's neonatal intensive care unit, the soothing voice and gentle touch of a loving parent can have a tremendous impact toward a positive outcome - that is, unless mom or dad's visit leaves the infant with something extra: a dangerous bacterial infection.

Global health community should save AMFm because it saves lives

The Affordable Medicines Facility-malaria began as a pilot program in 2010 to "provide a 'co-payment' to the manufacturers of [artemisinin-based combination therapies (ACTs)], thereby allowing commercial wholesalers and private or government health services to purchase the drugs at a fraction of the already low negotiated price," Kenneth Arrow, a Nobel laureate in economic sciences in 1972 and an emeritus professor of economics at Stanford University, writes in a New York Times opinion piece.

FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer (MTC). The FDA also granted priority review status for the new drug application and set a Prescription Drug User Fee Act (PDUFA) action date of 7 January 2011.

Read more Medical News

› Verified 5 days ago